Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

Clinical trial NCT04960618 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04960618
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mycosis Fungoides Mycosis Fungoides/Sezary Syndrome Sezary Syndrome Sézary Advanced Mycosis Fungoides

Start date: 2021-10-01
Primary completion: 2027-07-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.